TSHA peer analysis
Taysha Gene Therapies (TSHA) against its competitors: price, today's move, 1-year return and market value side by side.
TSHA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABEO Abeona Therapeutics | $4.18 | 6.89% | -14.25% | $241.32M |
| BNTC Benitec Biopharma | $9.54 | 10.42% | -44.81% | $323.77M |
| FDMT 4D Molecular | $12.25 | 8.89% | 4.74% | – |
| NGNE Neurogene | $25.31 | -1.33% | -19.40% | – |
| PASG Passage Bio | $3.46 | -1.42% | -52.05% | $11.29M |
| RCKT Rocket Pharmaceuticals | $2.39 | -1.89% | -25.99% | $286.51M |
| RGNX REGENXBIO | $7.62 | 3.25% | -36.25% | $508.96M |
| SRPT Sarepta Therapeutics | $17.82 | 1.42% | 5.56% | $2.01B |
| VYGR Voyager Therapeutics | $1.83 | 6.40% | -59.38% | $115.23M |
| TSHA Taysha Gene Therapies | $4.33 | 5.87% | -4.45% | – |
- TSHA's peers: ABEO (Abeona Therapeutics), BNTC (Benitec Biopharma), FDMT (4D Molecular), NGNE (Neurogene), PASG (Passage Bio), RCKT (Rocket Pharmaceuticals), RGNX (REGENXBIO), SRPT (Sarepta Therapeutics).
Updated 2026-11-07 11:54 UTC